for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sientra Inc

SIEN.OQ

Latest Trade

7.17USD

Change

0.19(+2.72%)

Volume

1,452,408

Today's Range

6.84

 - 

7.22

52 Week Range

4.79

 - 

24.73

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
6.98
Open
6.95
Volume
1,452,408
3M AVG Volume
19.81
Today's High
7.22
Today's Low
6.84
52 Week High
24.73
52 Week Low
4.79
Shares Out (MIL)
49.29
Market Cap (MIL)
338.63
Forward P/E
-2.49
Dividend (Yield %)
--

Latest Developments

More

Sientra Reports Q2 Loss Per Share $1.19

Sientra Commences Public Offering Of Common Stock

Sientra Files For Mixed Shelf Of Up To $150 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Sientra Inc

Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. TRUE Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders and a range of other aesthetic and specialty products. The Company offers a range of HSC+ breast implants, including anatomically shaped textured, round textured and round smooth. The Company also offers miraDry system, the device to reduce underarm sweat, odor and permanently reduce hair of all colors.

Industry

Medical Equipment & Supplies

Contact Info

420 S Fairview Ave Ste 200

+1.805.5623500

http://sientra.com/

Executive Leadership

Jeffrey M. Nugent

Chairman of the Board, Chief Executive Officer, Director

Paul Little

Chief Financial Officer, Senior Vice President, Treasurer

Charles Huiner

Chief Operating Officer, Senior Vice President - Corporate Development and Strategy

Nicholas J. Simon

Lead Independent Director

Keith J. Sullivan

Director

Key Stats

1.44 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.0K

2017

0.0K

2018

0.1K

2019(E)

0.1K
EPS (USD)

2016

-2.200

2017

-3.340

2018

-3.250

2019(E)

-2.760
Price To Earnings (TTM)
--
Price To Sales (TTM)
4.58
Price To Book (MRQ)
2.94
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
34.02
LT Debt To Equity (MRQ)
18.23
Return on Investment (TTM)
-73.41
Return on Equity (TTM)
-50.03

Latest News

CORRECTED-(OFFICIAL)-BRIEF-Sientra Reports Q2 Loss Per Share $1.10 (Aug. 8)

(Corrects second bullet, headline to say co reports Q2 loss per share of $1.10, not $1.19) Sientra Inc:

J&J and Sientra get FDA warning letters over breast implants

The U.S. Food and Drug Administration has issued warning letters to Sientra Inc and a Johnson & Johnson unit for failing to comply with the post-approval study requirements for their breast implants.

Sientra gets FDA warning letter for breast implants

The U.S. Food and Drug Administration has issued a warning letter to Sientra Inc for its silicone gel breast implants that were approved by the agency for breast augmentation and reconstruction procedures.

SEC sues U.S. breast-implant company's ex-CEO after stock dive

The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc <SIEN.O> for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.

SEC sues ex-CEO of California breast implant company after stock nosedived

The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.

BRIEF-Sientra Q1 Loss Per Share $0.99

* Q1 EARNINGS PER SHARE VIEW $-0.84 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Sientra Inc. Announces Closing Of $115 Mln Public Offering Of Common Stock

* SIENTRA, INC. ANNOUNCES CLOSING OF $115 MILLION PUBLIC OFFERING OF COMMON STOCK AND EXERCISE IN FULL OF UNDERWRITERS’ OVER-ALLOTMENT OPTION Source text for Eikon: Further company coverage:

BRIEF-Sientra Announces Pricing Of Upsized Public Offering Of Common Stock

* SIENTRA ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Sientra Inc Says Commenced Underwritten Public Follow-On Offering Of About $75 Mln Of Its Stock To Be Sold By Co

* SIENTRA INC - COMMENCED UNDERWRITTEN PUBLIC FOLLOW-ON OFFERING OF ABOUT $75 MILLION OF ITS STOCK TO BE SOLD BY COMPANY

BRIEF-Sientra Sees Preliminary Unaudited Net Sales For Q1 2018 Of About $14.5 Mln

* SIENTRA INC - SEES PRELIMINARY UNAUDITED NET SALES FOR Q1 2018 OF ABOUT $14.5 MILLION

BRIEF-Sientra Receives FDA Approval Of PMA Supplement

* SIENTRA INC - ADDITIONAL $10 MILLION OF EXISTING CREDIT FACILITY NOW ACCESSIBLE WITH FDA APPROVAL

BRIEF-Sientra Says Reached An Agreement-In-Principle With Staff Of Division Of Enforcement Of U.S. SEC

* SIENTRA INC - REACHED AN AGREEMENT-IN-PRINCIPLE WITH STAFF OF DIVISION OF ENFORCEMENT OF U.S. SECURITIES AND EXCHANGE COMMISSION - SEC FILING

BRIEF-Sientra Reports Qtrly Loss Per Share $0.92

* SIENTRA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Sientra Says Co Enters Into Agreement With Stifel, Nicolaus & Co Inc

* SIENTRA SAYS CO ENTERED INTO AGREEMENT WITH STIFEL, NICOLAUS & CO INC, TO SELL SHARES OF STOCK HAVING AN OFFERING PRICE OF UP TO $50 MILLION- SEC FILING Source text for Eikon: Further company coverage:

BRIEF-Sientra Provides Update On FDA Review Of U.S. Manufacturing Facility

* SIENTRA® PROVIDES UPDATE ON FDA REVIEW OF U.S. MANUFACTURING FACILITY

BRIEF-Sientra Announces Preliminary Unaudited Q4 Revenue

* SIENTRA ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER 2017 REVENUE

BRIEF-Sientra Inc Files For Mixed Shelf Of Upto $150 Million

* SIENTRA INC FILES FOR MIXED SHELF OF UPTO $150 MILLION - SEC FILING Source text (http://bit.ly/2ADjKzY) Further company coverage:

BRIEF-Sientra posts qtrly loss of $0.74​ per share

* Total net sales for Q3 2017 were $9.8 million, compared to total net sales of $6.5 million for same period in 2016

BRIEF-Sientra's ‍total net sales for Q3 2017 were $9.8 million

* Sientra - total net sales for Q3 2017 were $9.8 million, compared to $6.5 million for same period in 2016

BRIEF-Sientra reports Q2 net loss per share attributable to stockholders $1.07​

* Sientra Inc qtrly basic and diluted net loss per share attributable to common stockholders $1.07 Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up